Search Results - "Gamea Ayman"

Refine Results
  1. 1

    Multiple sclerosis diagnostic delay and its associated factors in Upper Egyptian patients by Khedr, Eman M., El Malky, Islam, Hussein, Hussein B., Mahmoud, Doaa M., Gamea, Ayman

    Published in Scientific reports (08-02-2023)
    “…The earlier the diagnosis of multiple sclerosis (MS), the sooner disease-modifying treatments can be initiated. However, significant delays still occur in…”
    Get full text
    Journal Article
  2. 2

    Depression and anxiety among patients with Parkinson’s disease: frequency, risk factors, and impact on quality of life by Khedr, Eman M, Abdelrahman, Ahmed A, Elserogy Yasser, Zaki Ahmed Fathi, Gamea Ayman

    “…BackgroundDepression and anxiety are non-motor symptoms of Parkinson’s disease (PD) that are often overlooked and underrated. This study aimed to highlight the…”
    Get full text
    Journal Article
  3. 3

    Cerebrovascular function in tension-type headache and migraine with or without aura: Transcranial Doppler study by Khedr, Eman M., Abbas, Mohammed A., Gamea, Ayman, Sadek, Mohamed A., Zaki, Ahmed F.

    Published in Scientific reports (18-08-2022)
    “…The aim of the current study was to determine whether tension-type headache (TTH) and migraine with or without aura have altered anterior and posterior…”
    Get full text
    Journal Article
  4. 4

    Post-stroke depression: frequency, risk factors, and impact on quality of life among 103 stroke patients—hospital-based study by Khedr, Eman M, Abdelrahman, Ahmed A, Desoky Tarek, Zaki Ahmed Fathi, Gamea Ayman

    “…BackgroundPost-stroke depression (PSD) has worse functional outcomes and quality of life. Despite the extensive literature on this topic, there is no agreement…”
    Get full text
    Journal Article
  5. 5

    Treatment satisfaction with disease-modifying therapy is the only predictor of Adherence among multiple sclerosis patients from Upper Egypt by Khedr, Eman M., Mahmoud, Doaa M., Hussein, Hussein B., Malky, Islam E. L., Mostafa, Sarah S., Gamea, Ayman

    Published in Scientific reports (25-03-2024)
    “…Despite the proven efficacy of the disease-modifying therapy (DMT) for multiple sclerosis (MS), the rates of non-adherence are frequently high. We aimed to…”
    Get full text
    Journal Article
  6. 6

    Prevalence of idiopathic epilepsy among primary school children in Qena City, Qena governorate, Egypt by Fawi, Gharib, Abbas, Mohamed A., Gamea, Ayman

    “…Background:Epilepsy among children is a common neurological disorder and may have a major impact on children development though epidemiological studies are…”
    Get full text
    Journal Article
  7. 7

    Cerebrovascular reactivity after functional activation of the Brain using Photic Stimulation in Migraine and Tension Type Headache: a transcranial doppler Ultrasonography Study by Khedr, Eman M, Abbas, Mohammed A, Gamea, Ayman, Sadek, Mohamed A, Zaki, Ahmed F

    Published in BMC neurology (17-03-2023)
    “…Previous studies in headache patients measured the cerebrovascular reactivity (CVR) in response to photic stimulation but they have yielded contradictory…”
    Get full text
    Journal Article
  8. 8

    Post-stroke dysphagia: frequency, risk factors, and topographic representation: hospital-based study by Khedr, Eman M, Abbass, Mohamed A, Soliman, Radwa K, Zaki, Ahmed F, Gamea Ayman

    “…BackgroundThe frequency of dysphagia varies considerably across literature. Post-stroke dysphagia is a common cause of increased morbidity and length of…”
    Get full text
    Journal Article
  9. 9

    Gut microbiota in Parkinson’s disease patients: hospital-based study by Khedr, Eman M, Ali, Anwar M, Deaf Enas, Hassan, Hebatallah M, Ahmed, Alaa, Gamea Ayman

    “…BackgroundParkinson’s disease (PD) is one of the most common neurodegenerative diseases. There is accumulating evidence that link gut microbiota to…”
    Get full text
    Journal Article
  10. 10

    Thalamic atrophy, duration of illness, and years of education are the best predictors of cognitive impairment in multiple sclerosis by Khedr, Eman M., Desoky, Tarek, Gamea, Ayman, Ezzeldin, Mohammed Y., Zaki, Ahmed F.

    Published in Clinical & experimental neuroimmunology (01-11-2022)
    “…Background Cognitive impairment (CI) is common in multiple sclerosis. We assessed the relationship between CI and demographic, motor disability, and volumetric…”
    Get full text
    Journal Article
  11. 11

    Cognitive impairment in patients with hepatitis C and non-hepatitis C non-alcoholic fatty liver disease: Hospital-based study by Zaki, Ahmed Fathy, Ghweil, Ali A., Hamada, Ahmed Omar, Gamea, Ayman

    “…Background: Non-alcoholic fatty liver disease (NAFLD) is important cause of hepatic morbidity worldwide. Recently, a significant association between NAFLD and…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Thalamic Atrophy, Duration of Illness, and Years of Education are the Best Predictors of Cognitive Impairment in Multiple Sclerosis by Khedr, Eman Mohamed, Desoky, Tarek, Gamea, Ayman, Ezzeldin, Mohammed Y., Zaki, Ahmed F.

    Published in Multiple sclerosis and related disorders (01-12-2023)
    “…Brain atrophy is quite extensive in multiple sclerosis (MS), occurring at a rate of 0.5–1.35% per year. Thalamus and other deep gray matter (GM) nuclei are…”
    Get full text
    Journal Article
  15. 15

    Fatigue and Brain Atrophy in Egyptian Patients with Relapsing Remitting Multiple Sclerosis by Khedr, Eman M, Desoky, Tarek, Gamea, Ayman, Ezzeldin, Mohamed Y., Zaki, Ahmed F.

    Published in Multiple sclerosis and related disorders (01-12-2023)
    “…Fatigue is the most troublesome symptom in relapsing remitting multiple sclerosis (RRMS). It starts early in the disease course, escalates with disease…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Multiple Sclerosis Diagnostic Delay and Its Associated Factors in Upper Egyptian Patients by Khedr, Eman M, Elmalky, Islam G, Hussein, Hussein B, Gamea, Ayman, Mahmoud, Doaa M.

    Published in Multiple sclerosis and related disorders (01-03-2023)
    “…The earlier the diagnosis of multiple sclerosis (MS) the sooner the disease modifying treatments (DMTs) can be initiated to achieve the treatment goals of…”
    Get full text
    Journal Article
  19. 19

    Adherence to Disease Modifying Treatment Among Multiple Sclerosis Patients from Upper Egypt by Khedr, Eman M, Elmalky, Islam G, Gamea, Ayman, Mahmoud, Doaa M., Hussein, Hussein Bahey-Eldeen

    Published in Multiple sclerosis and related disorders (01-03-2023)
    “…The rate of adherence to disease-modifying treatment (DMT) among patients with multiple sclerosis (MS) is often quite low, despite their proved benefits. DMT…”
    Get full text
    Journal Article
  20. 20

    Fatigue and brain atrophy in Egyptian patients with relapsing remitting multiple sclerosis by Khedr, Eman M, Desoky, Tarek, Gamea, Ayman, Ezzeldin, Mohammed Y, Zaki, Ahmed F

    Published in Multiple sclerosis and related disorders (01-07-2022)
    “…•Fatigue is common in RRMS and affecting 72.1% of patients.•Thalamus and brainstem volumes were significantly linked with fatigue.•EDSS of the patients may be…”
    Get full text
    Journal Article